Anti-NQO1 antibody - C-terminal (ab219769)

Goat polyclonal NQO1 antibody. Validated in WB, IHC and tested in Rat, Human, Pig. Immunogen corresponding to synthetic peptide.


  • Product name

    Anti-NQO1 antibody - C-terminal
    See all NQO1 primary antibodies
  • Description

    Goat polyclonal to NQO1 - C-terminal
  • Host species

  • Specificity

    ab219769 is expected to recognize all three reported isoforms (NP_000894.1, NP_001020604.1 and NP_001020605.1).
  • Tested applications

    Suitable for: WB, IHC-Pmore details
  • Species reactivity

    Reacts with: Rat, Human, Pig
    Predicted to work with: Mouse, Rabbit, Horse, Guinea pig, Dog, Monkey, Gorilla, Orangutan
  • Immunogen

    Synthetic peptide corresponding to Human NQO1 aa 263-274 (C terminal) (Cysteine residue). (NP_000894.1).


    Database link: P15559

  • Positive control

    • Human kidney tissue; human, rat and pig kidney lysates, human lung lysate.



Our Abpromise guarantee covers the use of ab219769 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.03 - 0.1 µg/ml. Predicted molecular weight: 31 kDa.
IHC-P Use a concentration of 5 µg/ml. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.


  • Function

    The enzyme apparently serves as a quinone reductase in connection with conjugation reactions of hydroquinons involved in detoxification pathways as well as in biosynthetic processes such as the vitamin K-dependent gamma-carboxylation of glutamate residues in prothrombin synthesis.
  • Sequence similarities

    Belongs to the NAD(P)H dehydrogenase (quinone) family.
  • Cellular localization

  • Information by UniProt
  • Database links

  • Alternative names

    • Azoreductase antibody
    • Cytochrome b 5 reductase antibody
    • DHQU antibody
    • DIA 4 antibody
    • DIA4 antibody
    • Diaphorase (NADH/NADPH) (cytochrome b 5 reductase) antibody
    • Diaphorase (NADH/NADPH) antibody
    • Diaphorase 4 antibody
    • Dioxin inducible 1 antibody
    • DT diaphorase antibody
    • DT-diaphorase antibody
    • DTD antibody
    • Menadione reductase antibody
    • NAD(P)H dehydrogenase [quinone] 1 antibody
    • NAD(P)H dehydrogenase quinone 1 antibody
    • NAD(P)H menadione oxidoreductase 1 dioxin inducible antibody
    • NAD(P)H quinone dehydrogenase 1 antibody
    • NAD(P)H: menadione oxidoreductase 1 dioxin inducible 1 antibody
    • NAD(P)H:menadione oxidoreductase 1 antibody
    • NAD(P)H:Quinone acceptor oxidoreductase type 1 antibody
    • NAD(P)H:quinone oxidoreductase 1 antibody
    • NAD(P)H:quinone oxireductase antibody
    • NMOR 1 antibody
    • NMOR I antibody
    • NMOR1 antibody
    • NMORI antibody
    • NQO 1 antibody
    • NQO1 antibody
    • NQO1_HUMAN antibody
    • Phylloquinone reductase antibody
    • QR 1 antibody
    • QR1 antibody
    • Quinone reductase 1 antibody
    see all


  • Immunohistochemical analysis of formalin-fixed, paraffin-embedded human kidney tissue labeling NQO1 with ab219769 at 5 µg/ml.

  • All lanes : Anti-NQO1 antibody - C-terminal (ab219769) at 1 µg/ml

    Lane 1 : Rat kidney lysate (in RIPA buffer)
    Lane 2 : Pig kidney lysate (in RIPA buffer)

    Lysates/proteins at 35 µg per lane.

    Developed using the ECL technique.

    Predicted band size: 31 kDa

  • Anti-NQO1 antibody - C-terminal (ab219769) at 0.03 µg/ml + Human kidney lysate (in RIPA buffer) at 35 µg

    Developed using the ECL technique.

    Predicted band size: 31 kDa

  • Anti-NQO1 antibody - C-terminal (ab219769) at 1 µg/ml + Human lung lysate (in RIPA buffer) at 35 µg

    Developed using the ECL technique.

    Predicted band size: 31 kDa


ab219769 has not yet been referenced specifically in any publications.

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab219769.
Please use the links above to contact us or submit feedback about this product.

For licensing inquiries, please contact

Sign up